Enterin raises $12.7M in series A

Neurodegenerative company Enterin Inc. (Philadelphia, Pa.) raised $12.7 million in a series A round led by New Ventures III. Undisclosed existing private investors also participated.

Enterin is developing lead candidate ENT-01 to treat constipation associated with Parkinson’s disease. President and CMO Denise Barbut said that in September, the company plans to begin the second part of a Phase II study of the candidate, which it hopes to complete in 1Q18...